These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 39098126)

  • 1. An N-terminal heptad repeat trimer-based peptide fusion inhibitor exhibits potent anti-H1N1 activity.
    Na H; Luo H; Wang J; Sun L; Gao X; Liang G; Ma Y; Meng Z
    Bioorg Med Chem; 2024 Sep; 111():117865. PubMed ID: 39098126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-benzyl 4,4-disubstituted piperidines as a potent class of influenza H1N1 virus inhibitors showing a novel mechanism of hemagglutinin fusion peptide interaction.
    de Castro S; Ginex T; Vanderlinden E; Laporte M; Stevaert A; Cumella J; Gago F; Camarasa MJ; Luque FJ; Naesens L; Velazquez S
    Eur J Med Chem; 2020 May; 194():112223. PubMed ID: 32220685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Small Molecule Targeting the Hemagglutinin Stalk of Influenza Viruses.
    Kim JI; Lee S; Lee GY; Park S; Bae JY; Heo J; Kim HY; Woo SH; Lee HU; Ahn CA; Bang HJ; Ju HS; Ok K; Byun Y; Cho DJ; Shin JS; Kim DY; Park MS; Park MS
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31167918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrocyclic peptides exhibit antiviral effects against influenza virus HA and prevent pneumonia in animal models.
    Saito M; Itoh Y; Yasui F; Munakata T; Yamane D; Ozawa M; Ito R; Katoh T; Ishigaki H; Nakayama M; Shichinohe S; Yamaji K; Yamamoto N; Ikejiri A; Honda T; Sanada T; Sakoda Y; Kida H; Le TQM; Kawaoka Y; Ogasawara K; Tsukiyama-Kohara K; Suga H; Kohara M
    Nat Commun; 2021 May; 12(1):2654. PubMed ID: 33976181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of Rupestonic Acid L-Ephedrine Derivatives with Preliminary
    Yong J; Lu C
    Curr Pharm Des; 2024; 30(18):1398-1403. PubMed ID: 38623973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Envelope-deforming antiviral peptide derived from influenza virus M2 protein.
    Jung Y; Kong B; Moon S; Yu SH; Chung J; Ban C; Chung WJ; Kim SG; Kweon DH
    Biochem Biophys Res Commun; 2019 Sep; 517(3):507-512. PubMed ID: 31375212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermonomer Interactions in Hemagglutinin Subunits HA1 and HA2 Affecting Hemagglutinin Stability and Influenza Virus Infectivity.
    Wang W; DeFeo CJ; Alvarado-Facundo E; Vassell R; Weiss CD
    J Virol; 2015 Oct; 89(20):10602-11. PubMed ID: 26269180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoechinulin B and its analogues as potential entry inhibitors of influenza viruses, targeting viral hemagglutinin.
    Chen X; Si L; Liu D; Proksch P; Zhang L; Zhou D; Lin W
    Eur J Med Chem; 2015 Mar; 93():182-95. PubMed ID: 25681711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporin G, an amphibian antimicrobial peptide against influenza and parainfluenza respiratory viruses: Insights into biological activity and mechanism of action.
    De Angelis M; Casciaro B; Genovese A; Brancaccio D; Marcocci ME; Novellino E; Carotenuto A; Palamara AT; Mangoni ML; Nencioni L
    FASEB J; 2021 Feb; 35(2):e21358. PubMed ID: 33538061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1,6-Bis[(benzyloxy)methyl]uracil derivatives-Novel antivirals with activity against HIV-1 and influenza H1N1 virus.
    Geisman AN; Valuev-Elliston VT; Ozerov AA; Khandazhinskaya AL; Chizhov AO; Kochetkov SN; Pannecouque C; Naesens L; Seley-Radtke KL; Novikov MS
    Bioorg Med Chem; 2016 Jun; 24(11):2476-2485. PubMed ID: 27112451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of 4-Aminopiperidines as Inhibitors of Influenza A Viral Entry That Are Synergistic with Oseltamivir.
    Gaisina IN; Peet NP; Cheng H; Li P; Du R; Cui Q; Furlong K; Manicassamy B; Caffrey M; Thatcher GRJ; Rong L
    J Med Chem; 2020 Mar; 63(6):3120-3130. PubMed ID: 32069052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.
    Su S; Zhu Y; Ye S; Qi Q; Xia S; Ma Z; Yu F; Wang Q; Zhang R; Jiang S; Lu L
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sialic acid-mimic peptides as hemagglutinin inhibitors for anti-influenza therapy.
    Matsubara T; Onishi A; Saito T; Shimada A; Inoue H; Taki T; Nagata K; Okahata Y; Sato T
    J Med Chem; 2010 Jun; 53(11):4441-9. PubMed ID: 20476787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arylazolyl(azinyl)thioacetanilide. Part 9: Synthesis and biological investigation of thiazolylthioacetamides derivatives as a novel class of potential antiviral agents.
    Zhan P; Wang L; Liu H; Chen X; Li X; Jiang X; Zhang Q; Liu X; Pannecouque C; Naesens L; De Clercq E; Liu A; Du G
    Arch Pharm Res; 2012 Jun; 35(6):975-86. PubMed ID: 22870806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-influenza virus activity of benzo[d]thiazoles that target heat shock protein 90.
    Lamut A; Gjorgjieva M; Naesens L; Liekens S; Lillsunde KE; Tammela P; Kikelj D; Tomašič T
    Bioorg Chem; 2020 May; 98():103733. PubMed ID: 32171985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel pandemic influenza A(H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein.
    Triana-Baltzer GB; Gubareva LV; Nicholls JM; Pearce MB; Mishin VP; Belser JA; Chen LM; Chan RW; Chan MC; Hedlund M; Larson JL; Moss RB; Katz JM; Tumpey TM; Fang F
    PLoS One; 2009 Nov; 4(11):e7788. PubMed ID: 19893747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of enisamium, an isonicotinic acid derivative, against influenza viruses in differentiated normal human bronchial epithelial cells.
    Boltz D; Peng X; Muzzio M; Dash P; Thomas PG; Margitich V
    Antivir Chem Chemother; 2018; 26():2040206618811416. PubMed ID: 30466301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational peptide engineering approach for selection of the new C05 antibody-driven peptide with potency to blocking influenza a virus attachment; from
    Gholami S; Mafakher L; Fotouhi F; Bambai B; Cohan RA; Mehrbod P; Shokouhi H; Farahmand B
    J Biomol Struct Dyn; 2024 Sep; 42(15):7730-7746. PubMed ID: 37553776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Porous gold nanoparticles for attenuating infectivity of influenza A virus.
    Kim J; Yeom M; Lee T; Kim HO; Na W; Kang A; Lim JW; Park G; Park C; Song D; Haam S
    J Nanobiotechnology; 2020 Mar; 18(1):54. PubMed ID: 32209114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory activity of selenium nanoparticles functionalized with oseltamivir on H1N1 influenza virus.
    Li Y; Lin Z; Guo M; Xia Y; Zhao M; Wang C; Xu T; Chen T; Zhu B
    Int J Nanomedicine; 2017; 12():5733-5743. PubMed ID: 28848350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.